HopeStage
Back to all studies
RecruitingNCT03537794

Brain imaging in treatment-resistant depression

About this titleRead the official source — NCT03537794
Observational studyAges 25–65Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 25 years to 65 years.

What will I do during this study?

The study compares three groups: people with depression that has not improved with treatment, people with depression, and healthy controls. The registry lists PET and PHNO brain scans for the study. It does not specify a visit schedule in the fields summarized here.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 22, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
45
Sponsor
Unity Health Toronto
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Diagnostic test
Locations
Canada
Age range
From 25 Years to 65 Years
Official registry ID
NCT03537794
Official title
Show the full official title

Characterizing Synaptic Density in Treatment Resistant Depression

Recruitment & locations

Currently recruiting

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Unity Health Toronto.

Who can participate?

Listed age limits: 25 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies